Zehbe I - Search Results

1

Rare human papillomavirus 16 E6 variants reveal significant oncogenic potential.

Zehbe I, Lichtig H, Westerback A, Lambert PF, Tommasino M, Sherman L. Zehbe I, et al. Mol Cancer. 2011 Jun 24;10:77. doi: 10.1186/1476-4598-10-77. Mol Cancer. 2011. PMID: 21702904 Free PMC article.

2

HPV16 E6 natural variants exhibit different activities in functional assays relevant to the carcinogenic potential of E6.

Lichtig H, Algrisi M, Botzer LE, Abadi T, Verbitzky Y, Jackman A, Tommasino M, Zehbe I, Sherman L. Lichtig H, et al. Among authors: zehbe i. Virology. 2006 Jun 20;350(1):216-27. doi: 10.1016/j.virol.2006.01.038. Epub 2006 Mar 6. Virology. 2006. PMID: 16519914 Free article.

3

Human papillomavirus 16 E6 variants differ in their dysregulation of human keratinocyte differentiation and apoptosis.

Zehbe I, Richard C, DeCarlo CA, Shai A, Lambert PF, Lichtig H, Tommasino M, Sherman L. Zehbe I, et al. Virology. 2009 Jan 5;383(1):69-77. doi: 10.1016/j.virol.2008.09.036. Epub 2008 Nov 4. Virology. 2009. PMID: 18986660 Free PMC article.

4

Sonoporation delivery of monoclonal antibodies against human papillomavirus 16 E6 restores p53 expression in transformed cervical keratinocytes.

Togtema M, Pichardo S, Jackson R, Lambert PF, Curiel L, Zehbe I. Togtema M, et al. Among authors: zehbe i. PLoS One. 2012;7(11):e50730. doi: 10.1371/journal.pone.0050730. Epub 2012 Nov 30. PLoS One. 2012. PMID: 23226365 Free PMC article.

5

Tumourigenesis driven by the human papillomavirus type 16 Asian-American e6 variant in a three-dimensional keratinocyte model.

Jackson R, Togtema M, Lambert PF, Zehbe I. Jackson R, et al. Among authors: zehbe i. PLoS One. 2014 Jul 1;9(7):e101540. doi: 10.1371/journal.pone.0101540. eCollection 2014. PLoS One. 2014. PMID: 24983759 Free PMC article.

6

Human papillomavirus 16 E6, L1, L2 and E2 gene variants in cervical lesion progression.

Lee K, Magalhaes I, Clavel C, Briolat J, Birembaut P, Tommasino M, Zehbe I. Lee K, et al. Among authors: zehbe i. Virus Res. 2008 Jan;131(1):106-10. doi: 10.1016/j.virusres.2007.08.003. Epub 2007 Sep 14. Virus Res. 2008. PMID: 17869365

7

The immortalizing and transforming ability of two common human papillomavirus 16 E6 variants with different prevalences in cervical cancer.

Richard C, Lanner C, Naryzhny SN, Sherman L, Lee H, Lambert PF, Zehbe I. Richard C, et al. Among authors: zehbe i. Oncogene. 2010 Jun 10;29(23):3435-45. doi: 10.1038/onc.2010.93. Epub 2010 Apr 12. Oncogene. 2010. PMID: 20383192

8

Increased risk for cervical disease progression of French women infected with the human papillomavirus type 16 E6-350G variant.

Grodzki M, Besson G, Clavel C, Arslan A, Franceschi S, Birembaut P, Tommasino M, Zehbe I. Grodzki M, et al. Among authors: zehbe i. Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):820-2. doi: 10.1158/1055-9965.EPI-05-0864. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16614130

9

Activities of human papillomavirus 16 E6 natural variants in human keratinocytes.

Asadurian Y, Kurilin H, Lichtig H, Jackman A, Gonen P, Tommasino M, Zehbe I, Sherman L. Asadurian Y, et al. Among authors: zehbe i. J Med Virol. 2007 Nov;79(11):1751-60. doi: 10.1002/jmv.20978. J Med Virol. 2007. PMID: 17854024

10

IFN-κ, a novel type I IFN, is undetectable in HPV-positive human cervical keratinocytes.

DeCarlo CA, Severini A, Edler L, Escott NG, Lambert PF, Ulanova M, Zehbe I. DeCarlo CA, et al. Among authors: zehbe i. Lab Invest. 2010 Oct;90(10):1482-91. doi: 10.1038/labinvest.2010.95. Epub 2010 May 17. Lab Invest. 2010. PMID: 20479716 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters